S L Hickenbottom
Overview
Explore the profile of S L Hickenbottom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
226
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Deng Y, Reeves M, Jacobs B, Birbeck G, Kothari R, Hickenbottom S, et al.
Neurology
. 2006 Feb;
66(3):306-12.
PMID: 16476927
Objective: To assess the use of IV recombinant tissue plasminogen activator (rt-PA) in a statewide hospital-based stroke registry and to identify factors associated with its use among eligible patients. Methods:...
2.
Hickenbottom S, Fendrick A, Kutcher J, Kabeto M, Katz S, Langa K
Neurology
. 2002 Jun;
58(12):1754-9.
PMID: 12084872
Background: As the US population ages, increased stroke incidence will result in higher stroke-associated costs. Although estimates of direct costs exist, little information is available regarding informal caregiving costs for...
3.
Burgin W, Staub L, Chan W, Wein T, Felberg R, Grotta J, et al.
Neurology
. 2001 Dec;
57(11):2006-12.
PMID: 11739817
Objective: To evaluate the practice patterns for stroke care in rural emergency departments (ED). Methods: The authors prospectively evaluated clinical practice decisions for all ED patients in two non-urban East...
4.
Felberg R, Krieger D, Chuang R, Persse D, Burgin W, Hickenbottom S, et al.
Circulation
. 2001 Oct;
104(15):1799-804.
PMID: 11591617
Background: No proven neuroprotective treatment exists for ischemic brain injury after cardiac arrest. Mild-to-moderate induced hypothermia (MIH) is effective in animal models. Methods And Results: A safety and feasibility trial...
5.
Wein T, Staub L, Felberg R, Hickenbottom S, Chan W, Grotta J, et al.
Stroke
. 2000 Aug;
31(8):1925-8.
PMID: 10926958
Background And Purpose: Activating emergency medical services (EMS) is the most important factor in reducing delay times to hospital arrival for stroke patients. Determining who calls 911 for stroke would...
6.
Hickenbottom S, Barsan W
Neurol Clin
. 2000 Apr;
18(2):379-97.
PMID: 10757832
Acute ischemic stroke is a medical emergency that requires rapid evaluation and treatment. Prehospital and emergency department care can be streamlined to meet those goals. Intravenous rt-PA therapy improves outcome...
7.
Hickenbottom S, Grotta J, Strong R, Denner L, Aronowski J
Stroke
. 1999 Nov;
30(11):2472-7; discussion 2477-8.
PMID: 10548686
Background And Purpose: Nuclear factor-kappaB (NF-kappaB) is a ubiquitous transcription factor that, when activated, translocates to the nucleus, binds to DNA, and promotes transcription of many target genes. Its activation...
8.
9.
Wein T, Hickenbottom S, Alexandrov A
Pharmacoeconomics
. 1999 May;
14(6):603-11.
PMID: 10346413
Stroke is the leading cause of long term disability and the third leading cause of death in the US. Nearly $US40.9 billion (1997 values) are spent each year on direct...
10.
Hickenbottom S, Grotta J
Semin Neurol
. 1999 Feb;
18(4):485-92.
PMID: 9932619
The concept of neuroprotection relies on the principle that delayed neuronal injury occurs after ischemia. The phenomenon of the "ischemic cascade" has been described, and each step along this cascade...